nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Gastrointestinal ulcer haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.0544	0.0544	CcSEcCtD
Telavancin—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.026	0.026	CcSEcCtD
Telavancin—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.026	0.026	CcSEcCtD
Telavancin—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.0197	0.0197	CcSEcCtD
Telavancin—Venous thrombosis—Cisplatin—peripheral nervous system neoplasm	0.0193	0.0193	CcSEcCtD
Telavancin—Extravasation—Topotecan—peripheral nervous system neoplasm	0.0186	0.0186	CcSEcCtD
Telavancin—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.0185	0.0185	CcSEcCtD
Telavancin—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.0185	0.0185	CcSEcCtD
Telavancin—Extravasation—Melphalan—peripheral nervous system neoplasm	0.0183	0.0183	CcSEcCtD
Telavancin—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.0171	0.0171	CcSEcCtD
Telavancin—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.0171	0.0171	CcSEcCtD
Telavancin—Ulcer—Melphalan—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Telavancin—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Telavancin—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Telavancin—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.0151	0.0151	CcSEcCtD
Telavancin—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.014	0.014	CcSEcCtD
Telavancin—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.0139	0.0139	CcSEcCtD
Telavancin—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.0136	0.0136	CcSEcCtD
Telavancin—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.0136	0.0136	CcSEcCtD
Telavancin—Extravasation—Vincristine—peripheral nervous system neoplasm	0.0135	0.0135	CcSEcCtD
Telavancin—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Telavancin—Abscess—Cisplatin—peripheral nervous system neoplasm	0.0132	0.0132	CcSEcCtD
Telavancin—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Telavancin—Necrosis—Etoposide—peripheral nervous system neoplasm	0.0122	0.0122	CcSEcCtD
Telavancin—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Telavancin—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Telavancin—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Telavancin—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Telavancin—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Telavancin—Extravasation—Etoposide—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Telavancin—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Telavancin—Hyperkalaemia—Cisplatin—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Telavancin—Ulcer—Etoposide—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Telavancin—Venous thrombosis—Epirubicin—peripheral nervous system neoplasm	0.00991	0.00991	CcSEcCtD
Telavancin—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00971	0.00971	CcSEcCtD
Telavancin—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00971	0.00971	CcSEcCtD
Telavancin—Venous thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.00917	0.00917	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00888	0.00888	CcSEcCtD
Telavancin—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00878	0.00878	CcSEcCtD
Telavancin—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Telavancin—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00804	0.00804	CcSEcCtD
Telavancin—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00759	0.00759	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00756	0.00756	CcSEcCtD
Telavancin—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00736	0.00736	CcSEcCtD
Telavancin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00695	0.00695	CcSEcCtD
Telavancin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00695	0.00695	CcSEcCtD
Telavancin—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Telavancin—Abscess—Epirubicin—peripheral nervous system neoplasm	0.00676	0.00676	CcSEcCtD
Telavancin—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00631	0.00631	CcSEcCtD
Telavancin—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00627	0.00627	CcSEcCtD
Telavancin—Abscess—Doxorubicin—peripheral nervous system neoplasm	0.00626	0.00626	CcSEcCtD
Telavancin—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.00613	0.00613	CcSEcCtD
Telavancin—Infection—Topotecan—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Telavancin—Infection—Tretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Telavancin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Telavancin—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Telavancin—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Telavancin—Infection—Melphalan—peripheral nervous system neoplasm	0.00565	0.00565	CcSEcCtD
Telavancin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00527	0.00527	CcSEcCtD
Telavancin—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.00526	0.00526	CcSEcCtD
Telavancin—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Telavancin—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00486	0.00486	CcSEcCtD
Telavancin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00468	0.00468	CcSEcCtD
Telavancin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Telavancin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Telavancin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Telavancin—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Telavancin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00449	0.00449	CcSEcCtD
Telavancin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Telavancin—Infection—Vincristine—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Telavancin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Telavancin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Telavancin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Telavancin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Telavancin—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Telavancin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Telavancin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Telavancin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00369	0.00369	CcSEcCtD
Telavancin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00369	0.00369	CcSEcCtD
Telavancin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Telavancin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Telavancin—Rash—Topotecan—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Telavancin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Telavancin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Telavancin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Telavancin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Telavancin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Telavancin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Telavancin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Telavancin—Rash—Melphalan—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Telavancin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Telavancin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Telavancin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Telavancin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Telavancin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Telavancin—Infection—Etoposide—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Telavancin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Telavancin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Telavancin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Telavancin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Telavancin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Telavancin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Telavancin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Telavancin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Telavancin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Telavancin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Telavancin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Telavancin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Telavancin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Telavancin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Telavancin—Rash—Vincristine—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Telavancin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Telavancin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Telavancin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Telavancin—Nausea—Vincristine—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Telavancin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Telavancin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Telavancin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Telavancin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Telavancin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Telavancin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Telavancin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Telavancin—Rash—Etoposide—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Telavancin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Telavancin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Telavancin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Telavancin—Infection—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Telavancin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Telavancin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Telavancin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Telavancin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Telavancin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Telavancin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Telavancin—Rash—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Telavancin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Telavancin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Telavancin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Telavancin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Telavancin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Telavancin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
